The Patent Finder

Terms ending in 2038

Adimab, LLC

Every in-force patent on Adimab, LLC's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,312,761Anti-Respiratory Syncytial Virus Antibodies, and Methods of Their Generation and Use
In force
 · High confidence
Gates Medical Research InstituteIn forceHigh confidence
US 11,661,460Anti-Coagulation Factor XI Antibodies
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,676,536Anti-Coagulation Factor XI Antibodies
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 10,836,810Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections
In force
 · High confidence
Albert Einstein College of MedicineIn forceHigh confidence
US 11,512,142Anti-Coagulation Factor XI Antibodies
In force
 · Medium confidence
Merck Sharp & Dohme LLCIn forceMedium confidence
US 11,479,615Anti-Coagulation Factor XI Antibodies
In force
 · Medium confidence
Merck Sharp & Dohme LLCIn forceMedium confidence
US 11,485,794Anti-Coagulation Factor XI Antibodies
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,242,378Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections
In force
 · High confidence
Albert Einstein College of MedicineIn forceHigh confidence
US 11,242,379Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections
In force
 · High confidence
Albert Einstein College of MedicineIn forceHigh confidence
US 11,407,816Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections
In force
 · High confidence
Albert Einstein College of MedicineIn forceHigh confidence
17 more term ends in 2038 · Pro
10 of 27 patents shown. Soonest term end first, then patent number.
Pro members see all 27.
Upgrade to Pro
3 of these are in force and held by Adimab, LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited